Home

PPI Platform

 

We have developed a new protein-protein interaction (PPI) small molecule inhibitor drug discovery platform.

 

Read more...

News

 

APG is participating at the 6 to 9 June 2016 BIO International Convention in San Francisco

 

Read more...

Pipeline

 

We have currently two drug discovery programs:

Huntington's disease and a transcription factor inhibitor for cancer treatment.

 

Read more...